BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32204871)

  • 1. Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients With Moderate Aortic Stenosis.
    Ito S; Miranda WR; Jaffe AS; Oh JK
    Am J Cardiol; 2020 May; 125(10):1566-1570. PubMed ID: 32204871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
    Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.
    Cemri M; Arslan U; Kocaman SA; Cengel A
    J Postgrad Med; 2008; 54(1):12-6. PubMed ID: 18296798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
    Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
    J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis.
    Barbieri F; Senoner T; Adukauskaite A; Dobner S; Holfeld J; Semsroth S; Lambert T; Zweiker D; Theurl T; Rainer PP; Schmidt A; Feuchtner GM; Steinwender C; Hoppe UC; Hintringer F; Bauer A; Müller S; Grimm M; Pfeifer BE; Dichtl W
    Am J Cardiol; 2019 Dec; 124(12):1932-1939. PubMed ID: 31699359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
    Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
    Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
    Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
    Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
    Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
    Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study.
    Dahou A; Clavel MA; Capoulade R; O'Connor K; Ribeiro HB; Côté N; Le Ven F; Rodés-Cabau J; Dumesnil JG; Mathieu P; Pibarot P
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):939-947. PubMed ID: 28917673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.
    Weber M; Arnold R; Rau M; Brandt R; Berkovitsch A; Mitrovic V; Hamm C
    Am J Cardiol; 2004 Sep; 94(6):740-5. PubMed ID: 15374777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptides and long-term mortality in patients with severe aortic stenosis.
    Katz M; Tarasoutchi F; Pesaro AE; Lopes RD; Spina GS; Vieira ML; Grinberg M
    J Heart Valve Dis; 2012 May; 21(3):331-6. PubMed ID: 22808834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.
    Weber M; Hausen M; Arnold R; Nef H; Moellman H; Berkowitsch A; Elsaesser A; Brandt R; Mitrovic V; Hamm C
    Heart; 2006 Nov; 92(11):1639-44. PubMed ID: 16740919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of balloon valvuloplasty in patients with severe aortic stenosis on levels of N-terminal pro-B-type natriuretic peptide.
    Spargias K; Alexopoulos E; Thomopoulou S; Dimopoulos A; Manginas A; Pavlides G; Voudris V; Karatassakis G; Athanassopoulos G; Cokkinos DV
    Am J Cardiol; 2009 Sep; 104(6):846-9. PubMed ID: 19733722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study.
    Luo C; Zhou J; Xiong S; Kang Z; Zhang J; Sun Y; Qin B; Fang K
    BMJ Open; 2019 Sep; 9(9):e029885. PubMed ID: 31492783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease.
    Bernard J; Jean G; Bienjonetti-Boudreau D; Jacques F; Tastet L; Salaun E; Clavel MA
    Open Heart; 2023 Jul; 10(2):. PubMed ID: 37474135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study.
    Cimadevilla C; Cueff C; Hekimian G; Dehoux M; Lepage L; Iung B; Duval X; Huart V; Tubach F; Vahanian A; Messika-Zeitoun D
    Heart; 2013 Apr; 99(7):461-7. PubMed ID: 23349346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.